Stock listing

LS Exchange:A1JCLA Mauna Kea Technologies SA Aktie

German listing (LS Exchange) of Mauna Kea Technologies SA · home listing Euronext:ALMKT

Follow Mauna Kea Technologies SA into a list and get an email when it puts out news.

Home listing price · EURONEXT:ALMKT

€0.114 EUR +0.004 (+3.6%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ALMKT

Since Jul 6, 2026 -30.2% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
€0.107 – €0.115 EUROct 16, 2026
Volume
688,456 sharesOct 16, 2026
Market value
€22.69M EURAt the close on Oct 16, 2026 · price × 199.1M shares outstanding
Mauna Kea Technologies SA logo
Ticker
LS Exchange:A1JCLA
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

Mauna Kea Technologies Announces 2026 Half-Year Results

Oct 8, 2026

Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Oct 6, 2026

Mauna Kea Technologies Announces Publication of a Landmark Systematic Review and Meta-Analysis Reinforcing the Diagnostic Accuracy and Clinical Impact of Cellvizio in Upper Gastrointestinal Cancer

Aug 26, 2026

Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts

Jul 28, 2026

Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth

Jul 21, 2026

Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity

Jul 16, 2026

Mauna Kea Technologies Secures €4.0M Shareholder Loan Agreement to Strengthen Liquidity and Fund Organic Growth

Jul 15, 2026

Mauna Kea Technologies Announces the Results of its Combined General Meeting of June 4, 2026

Jun 4, 2026

Mauna Kea Technologies Announces New Publication in the UEG Journal Identifying "Triple Healing", a Cellvizio®— Assessed Therapeutic Target Associated with Sustained Remission in Ulcerative Colitis

Jun 3, 2026

Mauna Kea Technologies Expands Presence in the Middle East with UAE and Turkey Regulatory Approvals and First CellTolerance® Commercial Installation

May 20, 2026

All Mauna Kea Technologies SA news

Financings

  • Shareholder current-account facility repayable in cash or new shares

    Oct 8, 2026 · US$4.58M

    Made bigger: €4M–€5M

    Buyers: Vester Finance (provides the shareholder current-account facility raised from €4.0 million to €5.0 million)

    Use of proceeds: Fund the Company's operations until the end of 2027

    Announced Jul 15, 2026 · Made bigger Oct 8, 2026

Read by 6ix AI from the company's releases

Decks

Mauna Kea Technologies SA on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
36 in the last 12 months · 57 in all · newest Oct 8, 2026 · oldest 2025
Decks
20 decks · latest Jul 21, 2026

Where Mauna Kea Technologies SA is listed

ListingExchangeCountryCurrency
Euronext:ALMKT · Home listingEuronextFranceEUR
LS Exchange:A1JCLA · This pageLS ExchangeGermanyEUR
Lang & Schwarz:A1JCLALang & SchwarzGermanyEUR
LSE:0P5ILSEUnited KingdomEUR
Aquis:ALMKTPAquisUnited KingdomEUR
Aquis:ALMKTPAquisUnited KingdomEUR
Frankfurt:1MKFrankfurtGermanyEUR
Munich:1MKMunichGermanyEUR
Stuttgart:1MKStuttgartGermanyEUR
Turquoise:ALMKTPTurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Mauna Kea Technologies SA.